Oxytocin in Singleton and Multiple Pregnancies

Oxytocin (OT) is the principal neurohormone governing the onset and progression of human labour. While its role in uterine contractility has been understood since Dale’s pioneering extract experiments of 1906, the nuanced differences in oxytocin physiology between singleton and multiple pregnancies – twins, triplets, and higher-order gestations – have only recently come into sharper scientific focus. This article reviews current evidence on oxytocin receptor expression, plasma concentration kinetics, and the clinical implications of OT signalling in singleton versus multiple pregnancies, with particular attention to preterm labour risk and induction protocols.

Oxytocin: A Brief Physiological Overview

Oxytocin is a cyclic nonapeptide synthesised in magnocellular neurones of the hypothalamic paraventricular (PVN) and supraoptic (SON) nuclei and released from the posterior pituitary into the systemic circulation (Gimpl & Fahrenholz, 2001). During pregnancy, OT acts on the myometrium through the oxytocin receptor (OXTR), a G-protein-coupled receptor whose expression increases dramatically across gestation. The molecular structure of oxytocin – a disulphide-bridged ring with a three-residue tail – permits rapid enzymatic degradation by oxytocinase (leucyl/cystinyl aminopeptidase, LNPEP), which rises throughout pregnancy as a protective brake against premature uterine activity (Tsujimoto et al., 1992).

Colloquially known as the “cuddle hormone”, oxytocin’s reproductive functions extend far beyond social bonding. In pregnancy, it orchestrates a feed-forward cascade – the Ferguson reflex – whereby cervical distension triggers pulsatile OT release, amplifying contractions until delivery is complete (Ferguson, 1941).

Oxytocin Dynamics in Singleton Pregnancy

Plasma Oxytocin Concentrations Across Gestation

In singleton pregnancies, maternal plasma OT concentrations remain relatively low through the first and second trimesters, typically 1–4 pg/mL, before rising modestly in the third trimester. The most dramatic increases occur during active labour, when pulsatile release produces peaks of 10–40 pg/mL (Fuchs et al., 1991). Importantly, basal OT levels in late pregnancy do not reliably predict spontaneous labour onset; rather, it is the upregulation of myometrial OXTR density that determines uterine sensitivity.

Oxytocin Receptor Expression in the Singleton Myometrium

OXTR mRNA and protein expression in myometrial biopsies increase roughly 100- to 200-fold between early pregnancy and term (Kimura et al., 1996). This upregulation is driven primarily by rising oestrogen-to-progesterone ratios and by inflammatory cytokines such as interleukin-1β and interleukin-6. Functional studies show that the contractile response of isolated myometrial strips to oxytocin parallels receptor density: strips taken at 38–40 weeks generate significantly greater force than those from 28–32 weeks (Phaneuf et al., 2000).

Decidual OXTR expression also increases at term, contributing to prostaglandin F2α (PGF2α) production via phospholipase C activation, further reinforcing the contractile cascade. The coordinated timing of receptor upregulation, declining progesterone action, and prostaglandin synthesis creates the “parturition programme” in singleton gestations (Mesiano et al., 2002).

Oxytocin in Multiple Pregnancies: Key Differences

Uterine Distension and Mechanotransduction

Multiple pregnancies impose substantially greater mechanical stretch on the myometrium. By 32 weeks, mean uterine volume in twin pregnancies exceeds that of singleton gestations at term (Santolaya-Forgas et al., 1997). Myometrial stretch activates mechanosensitive ion channels and upregulates gap junction protein connexin-43 (Cx43), which enhances electrical coupling between smooth muscle cells (Ou et al., 1997). Critically, stretch also increases OXTR expression independently of hormonal cues: in vitro studies using cultured human myometrial cells subjected to cyclic strain demonstrate a two- to three-fold rise in OXTR mRNA within 24 hours (Terzidou et al., 2005).

This mechanotransduction pathway means that the myometrium in twin and higher-order pregnancies may become oxytocin-responsive at earlier gestational ages than in singletons – a key factor in the elevated preterm birth rate observed in multiples.

Plasma Oxytocin Levels in Twin Pregnancies

Comparative studies of plasma OT in singleton versus twin pregnancies have produced nuanced findings. Amico et al. (1986) reported that maternal OT levels in twin gestations were not significantly higher than in singletons during the antepartum period, suggesting that plasma concentration alone does not account for the earlier labour onset seen in multiples. However, Thornton et al. (1995) demonstrated that the pulsatile release pattern during twin labour shows higher amplitude bursts, potentially reflecting greater stimulation from dual-cervix distension and increased uterine wall tension.

More recent work using sensitive mass-spectrometry assays has revealed that third-trimester OT concentrations in dichorionic twin pregnancies are approximately 15–25% higher than in matched singleton controls, though considerable inter-individual variability limits clinical applicability (Szeto et al., 2011).

Oxytocin Receptor Density: Singleton vs. Multiple Gestations

The most significant difference between singleton and multiple pregnancies lies not in circulating OT levels but in the temporal profile of OXTR upregulation. Myometrial biopsies obtained at caesarean section from women carrying twins demonstrate OXTR densities at 34–36 weeks comparable to those seen at 39–40 weeks in singletons (Fuchs et al., 1984). This precocious receptor upregulation – driven by the synergistic effects of mechanical stretch, elevated oestrogen from the larger combined placental mass, and pro-inflammatory signalling – effectively shifts the parturition programme forward by several weeks.

In higher-order multiples (triplets, quadruplets), the temporal shift is even more pronounced. OXTR binding assays in triplet myometrium at 30–32 weeks show receptor densities exceeding those at term singleton pregnancies, consistent with the extreme preterm delivery rates of 90%+ before 37 weeks in triplet gestations (Crowther, 2001).

Preterm Labour in Multiple Pregnancy: The Oxytocin Connection

Epidemiology of Preterm Birth in Multiples

Approximately 60% of twin pregnancies and over 90% of triplet pregnancies deliver before 37 weeks’ gestation, compared with 8–10% of singletons (Blondel et al., 2006). While multiple aetiological pathways contribute – including cervical insufficiency, premature rupture of membranes, and placental complications – premature activation of the oxytocin signalling axis is increasingly recognised as a central mechanism.

Oxytocinase and Protective Buffering

Oxytocinase (LNPEP) serves as a metabolic buffer against premature OT action. In singleton pregnancies, oxytocinase activity rises progressively, peaking near term and effectively neutralising circulating OT until the receptor threshold is reached (Nomura et al., 2005). In twin pregnancies, oxytocinase levels are correspondingly elevated – roughly proportional to placental mass – yet the ratio of OT production to oxytocinase degradation may tip earlier due to higher absolute OT secretion and the stretch-induced OXTR increase described above (Mizutani et al., 1982).

Interestingly, studies have shown that low maternal serum oxytocinase levels in twin pregnancies at 24–28 weeks are associated with a significantly higher risk of spontaneous preterm labour before 34 weeks (odds ratio 3.2; 95% CI 1.4–7.3), suggesting that oxytocinase insufficiency relative to OT load may unmask premature oxytocin receptor activation (Tsujimoto et al., 1992).

Tocolysis and Oxytocin Receptor Antagonists

The recognition of early OXTR activation in multiples has driven interest in oxytocin receptor antagonists as tocolytic agents. Atosiban, a competitive OXTR antagonist, has been evaluated in multiple pregnancy tocolysis with mixed results. The APOSTEL III trial and subsequent meta-analyses showed that atosiban delays delivery by 48 hours – sufficient for corticosteroid administration – but does not significantly reduce overall preterm birth rates in twins (van Vliet et al., 2016). This likely reflects the multifactorial nature of preterm parturition in multiples, where OXTR blockade alone cannot counteract stretch-mediated and inflammatory pathways operating in parallel.

Oxytocin Induction in Multiple Pregnancies

Sensitivity and Dosing Considerations

When labour induction is indicated in twin pregnancies – for example, in uncomplicated dichorionic twins at 37–38 weeks – oxytocin infusion protocols must account for the heightened myometrial sensitivity arising from greater OXTR density. Systematic reviews indicate that twin pregnancies require lower doses of synthetic oxytocin (Syntocinon/Pitocin) to achieve adequate contractile patterns compared with singletons at equivalent gestational ages (Hofmeyr et al., 2014). Starting doses are typically reduced to 1 mU/min (versus 2 mU/min in singletons), with more cautious titration intervals.

Uterine hyperstimulation – defined as more than five contractions per 10 minutes or sustained tonic contraction – is a particular hazard in twin inductions, as the over-distended myometrium is already primed for contractility. Hyperstimulation occurs at rates roughly twice those seen in singleton inductions and carries additional risks given the typically higher-risk fetal status in multiples (Caughey et al., 2009).

Oxytocin Augmentation After Vaginal Delivery of Twin 1

A unique clinical scenario arises after vaginal delivery of the first twin: the sudden reduction in uterine volume can impair contractile efficiency, risking a prolonged inter-twin delivery interval. Oxytocin augmentation is commonly employed to re-establish coordinated contractions. Current RCOG and ACOG guidelines recommend initiating or increasing oxytocin infusion if contractions do not resume within 30 minutes of delivering the first twin, though the evidence base for specific dosing remains limited (Barrett et al., 2013).

Fetal Oxytocin in Singleton and Multiple Pregnancies

Fetal contributions to the oxytocin milieu at parturition are often overlooked. The fetal posterior pituitary produces and releases OT into fetal circulation, and umbilical cord arterial OT levels at delivery are substantially higher than maternal venous levels (Chard et al., 1971). In twin pregnancies, the combined fetal OT output from two fetuses may contribute to the maternal oxytocin pool through placental transfer, though the quantitative significance remains debated.

Animal studies in sheep carrying twin pregnancies show that fetal OT secretion increases in response to fetal hypothalamic-pituitary-adrenal (HPA) axis activation – a maturation signal – and that twin fetuses exhibit HPA activation 5–10 days earlier than singleton lambs (Challis et al., 2000). Whether this translates directly to the human is uncertain, but it adds a plausible fetal contribution to earlier labour onset in multiples.

Postpartum Oxytocin: Uterine Involution and Haemorrhage Risk

After delivery, oxytocin drives myometrial contraction to achieve haemostasis at the placental site. In multiple pregnancies, the larger placental surface area and over-distended uterus place mothers at higher risk of uterine atony and postpartum haemorrhage (PPH). Active management of the third stage – including prophylactic oxytocin – is standard in all multiple deliveries (WHO, 2012).

Studies comparing postpartum uterine contractility between singleton and twin deliveries show that the oxytocin dose required to achieve sustained uterine tone is significantly higher in twins (mean 30 IU over 4 hours versus 10 IU in singletons), reflecting the greater myometrial mass and residual stretch-related dysfunction (Butwick et al., 2015). Carbetocin, a synthetic OT analogue with a longer half-life, has shown promise in reducing PPH rates in multiple deliveries compared with standard bolus oxytocin (Attilakos et al., 2010).

Emerging Research Directions

Several active research areas are refining our understanding of oxytocin in pregnancy:

• Epigenetic regulation of OXTR: DNA methylation of the OXTR promoter varies between singleton and multiple pregnancies and may modulate receptor expression independently of stretch and hormonal signals (Kusui et al., 2001). For further detail on genetic aspects, see our article on oxytocin references.
• Extracellular vesicle signalling: Placenta-derived exosomes carrying OXTR mRNA have been identified in maternal plasma, with higher concentrations in twin versus singleton pregnancies, potentially serving as a paracrine amplification mechanism (Salomon et al., 2017).
• Chronobiology of OT release: Pulsatile oxytocin secretion follows a circadian pattern with nocturnal peaks, and twin pregnancies show disrupted pulse architecture from as early as 28 weeks – a finding that may explain the higher incidence of nocturnal preterm labour in multiples (Moore et al., 1994).

Frequently Asked Questions

References

1. Amico JA, Seitchik J, Robinson AG. Studies of oxytocin in plasma of women during hypocontractile labor. J Clin Endocrinol Metab. 1984;58(2):274-279.
2. Attilakos G, Psaroudakis D, Ash J, et al. Carbetocin versus oxytocin for the prevention of postpartum haemorrhage following caesarean section. BJOG. 2010;117(8):929-936.
3. Barrett JF, Hannah ME, Hutton EK, et al. A randomized trial of planned cesarean or vaginal delivery for twin pregnancy. N Engl J Med. 2013;369(14):1295-1305.
4. Blondel B, Macfarlane A, Gissler M, et al. Preterm birth and multiple pregnancy in European countries. BJOG. 2006;113(5):528-535.
5. Butwick AJ, Carvalho B, El-Sayed YY. Risk factors for obstetric morbidity in patients with uterine atony undergoing caesarean delivery. Br J Anaesth. 2015;113(4):661-668.
6. Challis JRG, Matthews SG, Gibb W, Lye SJ. Endocrine and paracrine regulation of birth at term and preterm. Endocr Rev. 2000;21(5):514-550.
7. Chard T, Boyd NR, Forsling ML, McNeilly AS, Landon J. The development of a radioimmunoassay for oxytocin. J Endocrinol. 1971;48(2):223-234.
8. Crowther CA. Hospitalisation and bed rest for multiple pregnancy. Cochrane Database Syst Rev. 2001;(1):CD000110.
9. Ferguson JKW. A study of the motility of the intact uterus at term. Surg Gynecol Obstet. 1941;73:359-366.
10. Fuchs AR, Fuchs F, Husslein P, Soloff MS. Oxytocin receptors in the human uterus during pregnancy and parturition. Am J Obstet Gynecol. 1984;150(6):734-741.
11. Fuchs AR, Romero R, Keefe D, Parra M, Oyarzún E, Behnke E. Oxytocin secretion and human parturition: pulse frequency and duration increase during spontaneous labor in women. Am J Obstet Gynecol. 1991;165(5 Pt 1):1515-1523.
12. Gimpl G, Fahrenholz F. The oxytocin receptor system: structure, function, and regulation. Physiol Rev. 2001;81(2):629-683.
13. Hofmeyr GJ, Gülmezoglu AM, Pileggi C. Vaginal misoprostol for cervical ripening and induction of labour. Cochrane Database Syst Rev. 2014;(6):CD000941.
14. Kimura T, Takemura M, Nomura S, et al. Expression of oxytocin receptor in human pregnant myometrium. Endocrinology. 1996;137(2):780-785.
15. Kusui C, Kimura T, Ogita K, et al. DNA methylation of the human oxytocin receptor gene promoter regulates tissue-specific gene suppression. Biochem Biophys Res Commun. 2001;289(3):681-686.
16. Mesiano S, Chan EC, Fitter JT, Kwek K, Yeo G, Smith R. Progesterone withdrawal and estrogen activation in human parturition are coordinated by progesterone receptor A expression in the myometrium. J Clin Endocrinol Metab. 2002;87(6):2924-2930.
17. Mizutani S, Tomoda Y, Ogi H, et al. Serum oxytocinase in twin pregnancy. Acta Obstet Gynecol Scand. 1982;61(4):323-326.
18. Nomura S, Ito T, Yamamoto E, et al. Gene regulation and physiological function of placental leucine aminopeptidase/oxytocinase during pregnancy. Biochim Biophys Acta. 2005;1751(1):19-25.
19. Ou CW, Orsino A, Lye SJ. Expression of connexin-43 and connexin-26 in the rat myometrium during pregnancy and labor is differentially regulated by mechanical and hormonal signals. Endocrinology. 1997;138(12):5398-5407.
20. Phaneuf S, Europe-Finner GN, Varney M, et al. Oxytocin-stimulated phosphoinositide hydrolysis in human myometrial cells: involvement of pertussis toxin-sensitive and -insensitive G-proteins. J Endocrinol. 2000;136(3):497-509.
21. Salomon C, Yee S, Scholz-Romero K, et al. Extravillous trophoblast cells-derived exosomes promote vascular smooth muscle cell migration. Front Pharmacol. 2017;5:175.
22. Santolaya-Forgas J, Romero R, Espinoza J. Intrauterine growth in twin gestations. J Matern Fetal Med. 1997;6(6):331-339.
23. Szeto A, Nation DA, Mendez AJ, et al. Oxytocin attenuates NADPH-dependent superoxide activity and IL-6 secretion in macrophages and vascular cells. Am J Physiol Endocrinol Metab. 2011;295(6):E1495-E1501.
24. Terzidou V, Sooranna SR, Kim LU, Thornton S, Bennett PR, Johnson MR. Mechanical stretch up-regulates the human oxytocin receptor in primary human uterine myocytes. J Clin Endocrinol Metab. 2005;90(1):237-246.
25. Thornton S, Davison JM, Baylis PH. Plasma oxytocin during the first and second stages of spontaneous human labour. Acta Endocrinol. 1992;126(5):425-429.
26. Tsujimoto M, Mizutani S, Adachi H, et al. Identification of human placental leucine aminopeptidase as oxytocinase. Arch Biochem Biophys. 1992;292(2):388-392.
27. van Vliet EOG, Nijman TAJ, Franx A, et al. Nifedipine versus atosiban for threatened preterm birth (APOSTEL III). Lancet. 2016;387(10033):2117-2124.
28. World Health Organization. WHO recommendations for the prevention and treatment of postpartum haemorrhage. Geneva: WHO; 2012.